Paul R Leger

2PUBLICATIONS
1CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy.

Jeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar

|Apr 18, 2020
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.

Paul R Leger, Dennis X Hu, Berenger Biannic

Pageof 1

Frequent Collaborators

1 joint publications

Jeffrey J Jackson